NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.



Don't have an account? Subscribe

ADVERTISEMENT

ADVERTISEMENT

1,800 GPs sign up for chronic disease management, but pandemic slows progress

By Mindo - 29th May 2020

Incoming IMO President Dr Padraig McGarry

Approximately 1,800 GPs have signed up for the chronic disease management (CDM) programme however the current pandemic is slowing implementation, this newspaper has been told.

“The CDM agreement is in place,” Mr Val Moran IMO Director of Industrial Relations, General Practice, Public and Community Health told the Medical Independent (MI) on 27 May.

“But we are working with the HSE for a roll-out that takes into account the Covid-19 situation.”

Mr Moran said the current pandemic “has obviously slowed the implementation of the CDM programme”.

Mr Moran told this newspaper that approximately, 1,800 GPs have signed up the programme. The programme is not compulsory and it is up to individual GPs whether they want to sign-up.

Last year an agreement reached between the IMO and the Department of Health included the introduction of chronic disease management for three named diseases — chronic obstructive pulmonary disease (COPD), diabetes and cardiovascular disease.

The phased introduction of the CDM was due to start early this year, and by 2024, over 400,000 GMS/Doctor visit card patients were meant to be part of the chronic disease programme or a high-risk evaluation scheme.

“What has happened in the past is that GPs would look after patients with these conditions in an ad-hoc sort of way; there was no real structure to it,” Longford GP and IMO President Dr Padraig McGarry told MI last August.

“But we have formulated here a more structured approach to it, specific clinical and laboratory assessment made, advice given to patients at the end of each visit. There would [also] be a data return whereby the HSE would receive information about it.”

Leave a Reply

ADVERTISEMENT

Latest

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

Latest Issue
The Medical Independent 19th March 2024

You need to be logged in to access this content. Please login or sign up using the links below.

ADVERTISEMENT

Most Read

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT